Cargando…

Crystal structures and supra­molecular features of 9,9-dimethyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one, 3,7-di­aza­spiro­[bi­cyclo­[3.3.1]nonane-9,1′-cyclo­penta­ne]-2,4,6,8-tetra­one and 9-methyl-9-phenyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one di­methyl­formamide monosolvate

Compounds (I), C(9)H(10)N(2)O(4), (II), C(11)H(12)N(2)O(4), and (III), C(14)H(12)N(2)O(4)·C(3)H(7)NO represent 9,9-disubstituted-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one deriv­atives with very similar mol­ecular geometries for the bicyclic framework: the dihedral angle between the planes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Vatsadze, Sergey Z., Manaenkova, Marina A., Vasilev, Evgeny V., Venskovsky, Nikolai U., Khrustalev, Victor N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499299/
https://www.ncbi.nlm.nih.gov/pubmed/28775891
http://dx.doi.org/10.1107/S2056989017009458
_version_ 1783248447442255872
author Vatsadze, Sergey Z.
Manaenkova, Marina A.
Vasilev, Evgeny V.
Venskovsky, Nikolai U.
Khrustalev, Victor N.
author_facet Vatsadze, Sergey Z.
Manaenkova, Marina A.
Vasilev, Evgeny V.
Venskovsky, Nikolai U.
Khrustalev, Victor N.
author_sort Vatsadze, Sergey Z.
collection PubMed
description Compounds (I), C(9)H(10)N(2)O(4), (II), C(11)H(12)N(2)O(4), and (III), C(14)H(12)N(2)O(4)·C(3)H(7)NO represent 9,9-disubstituted-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one deriv­atives with very similar mol­ecular geometries for the bicyclic framework: the dihedral angle between the planes of the imide groups is 74.87 (6), 73.86 (3) and 74.83 (6)° in (I)–(III), respectively. The dimethyl derivative (I) is positioned on a crystallographic twofold axis and its overall geometry deviates only slightly from idealized C (2v) symmetry. The spiro-cyclo­pentane derivative (II) and the phen­yl/methyl analog (III) retain only inter­nal C (s) symmetry, which in the case of (II) coincides with crystallographic mirror symmetry. The cyclo­pentane moiety in (II) adopts an envelope conformation, with the spiro C atom deviating from the mean plane of the rest of the ring by 0.548 (2) Å. In compound (III), an N—H⋯O hydrogen bond is formed with the di­methyl­formamide solvent mol­ecule. In the crystal, both (I) and (II) form similar zigzag hydrogen-bonded ribbons through double inter­molecular N—H⋯O hydrogen bonds. However, whereas in (I) the ribbons are formed by two trans-arranged O=C—N—H amide fragments, the amide fragments are cis-positioned in (II). The formation of ribbons in (III) is apparently disrupted by participation of one of its N—H groups in hydrogen bonding with the solvent mol­ecule. As a result, the mol­ecules of (III) form zigzag chains rather than the ribbons through inter­molecular N—H⋯O hydrogen bonds. The crystal of (I) was a pseudo-merohedral twin.
format Online
Article
Text
id pubmed-5499299
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-54992992017-08-03 Crystal structures and supra­molecular features of 9,9-dimethyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one, 3,7-di­aza­spiro­[bi­cyclo­[3.3.1]nonane-9,1′-cyclo­penta­ne]-2,4,6,8-tetra­one and 9-methyl-9-phenyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one di­methyl­formamide monosolvate Vatsadze, Sergey Z. Manaenkova, Marina A. Vasilev, Evgeny V. Venskovsky, Nikolai U. Khrustalev, Victor N. Acta Crystallogr E Crystallogr Commun Research Communications Compounds (I), C(9)H(10)N(2)O(4), (II), C(11)H(12)N(2)O(4), and (III), C(14)H(12)N(2)O(4)·C(3)H(7)NO represent 9,9-disubstituted-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one deriv­atives with very similar mol­ecular geometries for the bicyclic framework: the dihedral angle between the planes of the imide groups is 74.87 (6), 73.86 (3) and 74.83 (6)° in (I)–(III), respectively. The dimethyl derivative (I) is positioned on a crystallographic twofold axis and its overall geometry deviates only slightly from idealized C (2v) symmetry. The spiro-cyclo­pentane derivative (II) and the phen­yl/methyl analog (III) retain only inter­nal C (s) symmetry, which in the case of (II) coincides with crystallographic mirror symmetry. The cyclo­pentane moiety in (II) adopts an envelope conformation, with the spiro C atom deviating from the mean plane of the rest of the ring by 0.548 (2) Å. In compound (III), an N—H⋯O hydrogen bond is formed with the di­methyl­formamide solvent mol­ecule. In the crystal, both (I) and (II) form similar zigzag hydrogen-bonded ribbons through double inter­molecular N—H⋯O hydrogen bonds. However, whereas in (I) the ribbons are formed by two trans-arranged O=C—N—H amide fragments, the amide fragments are cis-positioned in (II). The formation of ribbons in (III) is apparently disrupted by participation of one of its N—H groups in hydrogen bonding with the solvent mol­ecule. As a result, the mol­ecules of (III) form zigzag chains rather than the ribbons through inter­molecular N—H⋯O hydrogen bonds. The crystal of (I) was a pseudo-merohedral twin. International Union of Crystallography 2017-06-30 /pmc/articles/PMC5499299/ /pubmed/28775891 http://dx.doi.org/10.1107/S2056989017009458 Text en © Vatsadze et al. 2017 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/2.0/uk/
spellingShingle Research Communications
Vatsadze, Sergey Z.
Manaenkova, Marina A.
Vasilev, Evgeny V.
Venskovsky, Nikolai U.
Khrustalev, Victor N.
Crystal structures and supra­molecular features of 9,9-dimethyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one, 3,7-di­aza­spiro­[bi­cyclo­[3.3.1]nonane-9,1′-cyclo­penta­ne]-2,4,6,8-tetra­one and 9-methyl-9-phenyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one di­methyl­formamide monosolvate
title Crystal structures and supra­molecular features of 9,9-dimethyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one, 3,7-di­aza­spiro­[bi­cyclo­[3.3.1]nonane-9,1′-cyclo­penta­ne]-2,4,6,8-tetra­one and 9-methyl-9-phenyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one di­methyl­formamide monosolvate
title_full Crystal structures and supra­molecular features of 9,9-dimethyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one, 3,7-di­aza­spiro­[bi­cyclo­[3.3.1]nonane-9,1′-cyclo­penta­ne]-2,4,6,8-tetra­one and 9-methyl-9-phenyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one di­methyl­formamide monosolvate
title_fullStr Crystal structures and supra­molecular features of 9,9-dimethyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one, 3,7-di­aza­spiro­[bi­cyclo­[3.3.1]nonane-9,1′-cyclo­penta­ne]-2,4,6,8-tetra­one and 9-methyl-9-phenyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one di­methyl­formamide monosolvate
title_full_unstemmed Crystal structures and supra­molecular features of 9,9-dimethyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one, 3,7-di­aza­spiro­[bi­cyclo­[3.3.1]nonane-9,1′-cyclo­penta­ne]-2,4,6,8-tetra­one and 9-methyl-9-phenyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one di­methyl­formamide monosolvate
title_short Crystal structures and supra­molecular features of 9,9-dimethyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one, 3,7-di­aza­spiro­[bi­cyclo­[3.3.1]nonane-9,1′-cyclo­penta­ne]-2,4,6,8-tetra­one and 9-methyl-9-phenyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one di­methyl­formamide monosolvate
title_sort crystal structures and supra­molecular features of 9,9-dimethyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one, 3,7-di­aza­spiro­[bi­cyclo­[3.3.1]nonane-9,1′-cyclo­penta­ne]-2,4,6,8-tetra­one and 9-methyl-9-phenyl-3,7-di­aza­bicyclo­[3.3.1]nonane-2,4,6,8-tetra­one di­methyl­formamide monosolvate
topic Research Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499299/
https://www.ncbi.nlm.nih.gov/pubmed/28775891
http://dx.doi.org/10.1107/S2056989017009458
work_keys_str_mv AT vatsadzesergeyz crystalstructuresandsupramolecularfeaturesof99dimethyl37diazabicyclo331nonane2468tetraone37diazaspirobicyclo331nonane91cyclopentane2468tetraoneand9methyl9phenyl37diazabicyclo331nonane2468tetraonedimethylformamidemonosolvate
AT manaenkovamarinaa crystalstructuresandsupramolecularfeaturesof99dimethyl37diazabicyclo331nonane2468tetraone37diazaspirobicyclo331nonane91cyclopentane2468tetraoneand9methyl9phenyl37diazabicyclo331nonane2468tetraonedimethylformamidemonosolvate
AT vasilevevgenyv crystalstructuresandsupramolecularfeaturesof99dimethyl37diazabicyclo331nonane2468tetraone37diazaspirobicyclo331nonane91cyclopentane2468tetraoneand9methyl9phenyl37diazabicyclo331nonane2468tetraonedimethylformamidemonosolvate
AT venskovskynikolaiu crystalstructuresandsupramolecularfeaturesof99dimethyl37diazabicyclo331nonane2468tetraone37diazaspirobicyclo331nonane91cyclopentane2468tetraoneand9methyl9phenyl37diazabicyclo331nonane2468tetraonedimethylformamidemonosolvate
AT khrustalevvictorn crystalstructuresandsupramolecularfeaturesof99dimethyl37diazabicyclo331nonane2468tetraone37diazaspirobicyclo331nonane91cyclopentane2468tetraoneand9methyl9phenyl37diazabicyclo331nonane2468tetraonedimethylformamidemonosolvate